Mechanistic Insights into Transplantation Immunology: Immune Regulation and Tolerance

A Special Issue of Biomedicines (ISSN 2227-9059) belonging to the section "Immunology and Immunotherapy".

Deadline for manuscript submissions: 30 April 2027 | Viewed by 279

Editor


E-Mail Website
Guest Editor
Division of Transplantation Immunology, National Research Institute for Child Health and Development, Tokyo, Japan
Interests: transplantation immunology; immune tolerance; tumor immunology

Special Issue Information

Dear Colleagues,

Organ transplantation has transformed the management of end-stage organ failure, yet long-term graft survival remains limited by acute and chronic rejection, immunosuppressive toxicity, infection, malignancy, and the incomplete induction of donor-specific tolerance. These challenges reflect a complex and dynamic interaction among donor alloantigens, antigen-presenting cells, effector and regulatory lymphocytes, innate immune populations, stromal cells, metabolic programs, and tissue-specific microenvironments.

This Special Issue, "Mechanistic Insights into Transplantation Immunology: Immune Regulation and Tolerance", will highlight recent advances in the cellular and molecular mechanisms that determine graft injury, adaptation, and durable immune acceptance. We welcome original research articles, reviews, and perspectives addressing donor-antigen recognition and presentation; T- and B-cell regulation; regulatory CD8+ T-cell populations; dendritic-cell and macrophage biology; immune checkpoints; ischemia–reperfusion injury; immunometabolism; microbiota–immune interactions; extracellular vesicle-mediated communication; and mechanisms of operational tolerance. Studies using single-cell sequencing, spatial omics, high-dimensional cytometry, systems immunology, organoid or animal models, and well-characterized clinical cohorts are particularly encouraged.

The Special Issue also aims to bridge mechanistic discovery and clinical translation. Contributions may examine biomarkers for rejection or tolerance, mechanisms of immunosuppressive drug response and resistance, strategies for immune monitoring, and emerging approaches to minimize systemic immunosuppression while preserving protective immunity. By integrating basic, translational, and clinical perspectives across solid-organ transplantation, this collection seeks to define actionable pathways for individualized immune regulation and improved long-term graft and patient outcomes.

Dr. Xin Hu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • transplantation immunology
  • immune tolerance
  • allorecognition
  • regulatory CD8+ T cells
  • immunometabolism

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

20 pages, 8880 KB  
Article
Euonymus alatus-Derived Extracellular Vesicles Show Immunomodulatory Effects in an Inflammatory Thyroid Follicular Cell Model: Insights from Multi-Omics Analysis
by Yang Li, Yanqiong He, Yi Guo, Chuan Hua, Xin-He Zuo, Man Tian and Yong Zhao
Biomedicines 2026, 14(10), 2201; https://doi.org/10.3390/biomedicines14102201 - 29 Sep 2026
Abstract
Objectives: To extract and identify extracellular vesicles (EVs) derived from the traditional Chinese herb Euonymus alatus (EA), characterize their molecular profiles using multi-omics analysis, and assess their regulatory effects and potentially associated signaling pathways in an interferon-γ (IFN-γ)-stimulated inflammatory thyroid follicular cell [...] Read more.
Objectives: To extract and identify extracellular vesicles (EVs) derived from the traditional Chinese herb Euonymus alatus (EA), characterize their molecular profiles using multi-omics analysis, and assess their regulatory effects and potentially associated signaling pathways in an interferon-γ (IFN-γ)-stimulated inflammatory thyroid follicular cell model mimicking key inflammatory features of autoimmune thyroiditis (AIT). Methods: Differential centrifugation combined with density gradient centrifugation was used to purify EA-derived EVs, and the isolates were characterized using a BCA protein assay, transmission electron microscopy (TEM), nanoparticle tracking analysis (NTA), and Western blotting (WB). Molecular constituents were examined via label-free proteomics and RNA-seq. Meanwhile, Nthy-ori-3-1 cells were exposed to IFN-γ to establish an inflammatory thyroid follicular cell model; these activated cells were subsequently treated with the purified EVs (EV group). The supernatants were collected and the levels of interleukin-1β (IL-1β) and interleukin-18 (IL-18) were determined by ELISA. Comparative transcriptomic and proteomic profiling was employed to identify differentially expressed molecules and related signaling pathways between the model and the EV group. Results: EA-derived EVs were successfully isolated and showed typical EV characteristics. Proteomics identified 3607 proteins enriched in metabolic, immune, and antioxidant processes, while RNA-seq generated 72.16 million clean reads and revealed genes enriched in metabolic and immune pathways. In the IFN-γ-stimulated Nthy-ori-3-1 cells, ELISA results showed that EV treatment significantly reduced the secretion of IL-1β and IL-18 compared to the model group. EV intervention resulted in 138 differential proteins (42 upregulated, 96 downregulated) and 262 differential genes (81 upregulated, 181 downregulated). GO analysis revealed significant enrichment in terms related to inflammatory response, immune response, and regulation of oxidative stress. KEGG pathway analysis demonstrated enrichment in the IL-17, NOD-like receptor, and PPAR signaling pathways, as well as ferroptosis, and Wnt pathway (unique for upregulated genes). Conclusions: EA-derived EVs are rich in molecules that regulate metabolic pathways and immune responses. They may ameliorate inflammation in this inflammatory thyroid follicular cell model, with multi-omics analyses revealing correlative enrichment of multiple signaling pathways. These findings provide preliminary experimental evidence and novel candidate targets for AIT treatment. Full article
►▼ Show Figures

Graphical abstract

Back to TopTop